All the speakers for JDRF’s research open day event in Sheffield have now been confirmed. The day is for anyone with an interest in type 1 diabetes, and the varied, easy-to-understand presentations will offer something for everyone, covering all of the current hot topics in type 1 diabetes...

People with type 1 diabetes who have already been successful in achieving recommended blood sugar goals can further benefit from using continuous glucose monitoring (CGM) devices, according to JDRF funded research. According to the study, published in the journal Diabetes Care, using CGM devices...

JDRF Chief Executive, Karen Addington, has spoken out on the need for improved access to treatments for type 1 diabetes and the importance of funding research into the prevention and cure of the condition. This followed the announcement that the number of under fives in Europe with type 1 diabetes...

JDRF funded researchers at King’s College London and the University of Bristol have shown that a potential immune system therapy for type 1 diabetes is safe. Peptide immunotherapy is a type of treatment that uses small proteins to ‘reset’ the immune system to a healthy state, much like an allergy...

JDRF has launched a new pocket guide to type 1 diabetes. ‘Understanding type 1 diabetes, a pocket guide’ aims to address some of the myths surrounding the condition and highlights the distinction between type 1 and type 2 diabetes. JDRF hopes the guide will help to emphasise that the causes of type...